• No results found

18 results with keyword: 'mobility endothelial angiogenic vitreous patients proliferative diabetic retinopathy'

High-Mobility Group Box-1 and Endothelial Cell Angiogenic Markers in the Vitreous from Patients with Proliferative Diabetic Retinopathy

The aim of this study was to measure the levels of high-mobility group box-1 (HMGB1) in the vitreous fluid from patients with proliferative diabetic retinopathy (PDR) and to

Protected

N/A

8
0
0
2021
Effectiveness of prophylactic intravitreal bevacizumab injection to proliferative diabetic retinopathy patients with elevated preoperative intraocular VEGF in preventing complications after vitrectomy

injections for the prevention of post-vitrectomy complications in proliferative diabetic retinopathy (PDR) patients with elevated vitreous vascular endothelial growth factor

Protected

N/A

8
0
0
2020
Angiogenic potential of vitreous from proliferative diabetic retinopathy and eales' disease patients

We have previously observed this commonality in the presence of inflammatory cytokines [interleukin-6 (IL-6), interleukin-8 (IL-8), monocyte chemoat- tractant protein-1 (MCP-1)]

Protected

N/A

9
0
0
2021
Central subfield thickness and cube average thickness as bioimaging biomarkers for ellipsoid zone disruption in diabetic retinopathy

VEGF: vascular endothelial growth factor; DR: diabetic retinopathy; DME: diabetic macular edema; NPDR: non-proliferative diabetic retinopathy; PDR: proliferative diabetic

Protected

N/A

5
0
0
2020
A long term "memory" of HIF induction in response to chronic mild decreased oxygen after oxygen normalization

The first goal of this paper was to determine whether chronic exposure to mild decreased oxygen (15% O 2 ) induces the HIF signaling system in blood vessels. The sec- ond goal was

Protected

N/A

14
0
0
2020
Postvitrectomy diabetic vitreous hemorrhage in  proliferative diabetic retinopathy

There are multiple potential underlying etiologies for PDVH, including fibrovascular ingrowth at the sclerotomy sites, residual or recurrent neovascular membrane on the Table 1:

Protected

N/A

7
0
0
2022
Association of diabetic nephropathy with diabetic retinopathy in type 2 diabetes mellitus patients

Based on fundoscopy, patients were further classified into Non-Proliferative Diabetic Retinopathy (NPDR), Proliferative Diabetic Retinopathy (PDR) and those having

Protected

N/A

5
0
0
2020
Optical Coherence Tomography Features of Active and Inactive Retinal Neovascularization in Proliferative Diabetic Retinopathy

neovascularization in proliferative diabetic retinopathy identified 5 distinct signs of disease activity: presence of hyperreflective dots in the vitreous,

Protected

N/A

28
0
0
2021
Upregulation of thrombin/matrix metalloproteinase-1/protease-activated receptor-1 chain in proliferative diabetic retinopathy

The expressions of thrombin (A) and matrix metalloproteinase-1 (MMP-1) (B) in equal volumes (15 μL) of vitreous samples from patients with proliferative diabetic retinopathy (PDR)

Protected

N/A

22
0
0
2021
Characterisation of the vitreous proteome in proliferative diabetic retinopathy

Excluding the serum proteins from minor vitreous haemorrhage, 19 proteins were found to be differentially produced in PDR patients compared with normal subjects; 6 of these

Protected

N/A

11
0
0
2020
Cytokine Levels in Human Vitreous in Proliferative Diabetic Retinopathy

Levels of interleukin-8 (IL-8), IL-15, IL-16, vascular endothelial growth factor (VEGF), VEGF- D, c-reactive protein (CRP), serum amyloid-A (SAA), and intracellular adhesion

Protected

N/A

10
0
0
2021
Pars Plana Vitrectomy Reoperations for Complications of Proliferative Diabetic Retinopathy

Abbreviations: PDR, proliferative diabetic retinopathy; BCVA, best-corrected visual acuity; TRD, tractional retinal detachment; NCVH, non-clearing vitreous hemorrhage..

Protected

N/A

5
0
0
2020
ANCIS I N C O R P O R A T E D

The DOE Air Management Tool is a free Excel tool for g assessing the data center air-management status and providing recommendations and energy

Protected

N/A

20
0
0
2021
AMA Aboriginal and Torres Strait Islander Health Audit Report 2012: Progress to Date and Challenges that Remain

Mainstream primary care services, such as private general practices and community health clinics, also have a strong potential to improve the quality of the primary care they

Protected

N/A

24
0
0
2021
Quantitative proteomics analysis of vitreous body from type 2 diabetic patients with proliferative diabetic retinopathy

APOF: Apolipoprotein; APOH: Apolipoprotein H; BCA: Bicinchoninic acid; C2: Complement C2; C4BPA: C4b-binding protein alpha chain; C4BPA: Complement component 4 binding protein

Protected

N/A

12
0
0
2020
Proliferative Diabetic Retinopathy: An Overview of Vitreous Immune and Biomarkers

There are several biomarkers that can be found in diabetic retinopathy patients including biomarkers of oxidative stress, hypoxia- inducible factors, angiogenic

Protected

N/A

23
0
0
2021
Choosing preclinical study models of diabetic retinopathy: key problems for consideration

DR, diabetic retinopathy; NPDR, nonproliferative diabetic retinopathy; OIR, oxygen-induced retinopathy; PDR, proliferative diabetic retinopathy; STZ, streptozotocin; VEGF,

Protected

N/A

9
0
0
2020
IR - PERPUSTAKAAN UNIVERSITAS AIRLANGGA DAFTAR PUSTAKA

Global Humanitarian Assistance, 2014, Global Humanitarian Assistance Report Middle East Eye, 2015, „Analysis : Energy Deals Partly Behind Warming Turkey. Israel Relations‟ diakses

Protected

N/A

6
0
0
2021

Upload more documents and download any material studies right away!